| 2026-09-14 | Trial | New trial registered: Danish Trial of Weight Loss to Reduce Atrial Fibrillation Progression | Trial register ClinicalTrials.gov |
| 2026-09-14 | Trial | New trial registered: Post-Prandial Carbohydrate Metabolism in Individuals With and Without Post-Bariatric Surgery Hypoglycemia (PBH) | Trial register ClinicalTrials.gov |
| 2026-08-24 | Trial | New trial registered: Weight and Metabolic Management Study | Trial register ClinicalTrials.gov |
| 2026-08-24 | Trial | New trial registered: Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib | Trial register ClinicalTrials.gov |
| 2026-08-20 | Trial | New trial registered: Dietary Supplement for Telogen Effluvium Associated With GLP-1 Receptor Agonist Use | Trial register ClinicalTrials.gov |
| 2026-08-18 | Trial | New trial registered: GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry | Trial register ClinicalTrials.gov |
| 2026-08-18 | Trial | New trial registered: Semaglutide in Youth With Autism Spectrum Disorder | Trial register ClinicalTrials.gov |
| 2026-08-13 | Trial | New trial registered: Effect of GLP-1 Receptor Agonists on Periodontal Health and Response to Nonsurgical Periodontal Therapy | Trial register ClinicalTrials.gov |
| 2026-08-11 | Label | FDA label revised: Glucagon (ANDA208086) | Regulator FDA drug label register |
| 2026-08-11 | Trial | New trial registered: Mazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled Trial | Trial register ClinicalTrials.gov |
| 2026-08-10 | Results | Results posted: A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity | Trial register ClinicalTrials.gov |
| 2026-08-10 | Trial | New trial registered: Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008) | Trial register ClinicalTrials.gov |
| 2026-08-07 | Trial | New trial registered: Comparing Facial Aging Between Identical Twins With 3D Imaging | Trial register ClinicalTrials.gov |
| 2026-08-05 | Trial | New trial registered: Effects of N-Acyl Taurines on Incretin Levels in Healthy Subjects | Trial register ClinicalTrials.gov |
| 2026-08-05 | Trial | New trial registered: Plasma GLP-2 Dynamics and Acute Radiation Enteritis After Abdominopelvic Radiotherapy | Trial register ClinicalTrials.gov |
| 2026-08-05 | Trial | New trial registered: GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD | Trial register ClinicalTrials.gov |
| 2026-08-03 | Results | Results posted: Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects | Trial register ClinicalTrials.gov |
| 2026-08-03 | Trial | New trial registered: GLP-1s in Hip and Knee Arthroplasty | Trial register ClinicalTrials.gov |
| 2026-07-31 | Trial | New trial registered: Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Pa | Trial register ClinicalTrials.gov |
| 2026-07-30 | Trial | New trial registered: A Clinical Trial Evaluating TQF3250 Capsules in Patients With Type 2 Diabetes Mellitus and Overweight/Obesity | Trial register ClinicalTrials.gov |
| 2026-07-30 | Trial | New trial registered: Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome | Trial register ClinicalTrials.gov |
| 2026-07-30 | Trial | New trial registered: Gestational Response, Outcomes, and Weight After GLP-1 Use | Trial register ClinicalTrials.gov |
| 2026-07-29 | Federal Register | Federal Register notice: Product-Specific Guidances; Revised Draft Guidances for Industry; Availability | Regulator Federal Register |
| 2026-07-29 | Trial | New trial registered: Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial | Trial register ClinicalTrials.gov |
| 2026-07-29 | Trial | New trial registered: Tirzepatide for Treatment of CCCA | Trial register ClinicalTrials.gov |
| 2026-07-27 | Trial | New trial registered: Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients | Trial register ClinicalTrials.gov |
| 2026-07-23 | Label | FDA label revised: Glucagon (ANDA208086) | Regulator FDA drug label register |
| 2026-07-21 | Trial | New trial registered: Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients | Trial register ClinicalTrials.gov |
| 2026-07-20 | Trial | New trial registered: A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants | Trial register ClinicalTrials.gov |
| 2026-07-19 | Trial | New trial registered: Bariatric Surgery Combined With GLP-1RA: A Multicenter Study. | Trial register ClinicalTrials.gov |
| 2026-07-19 | Trial | New trial registered: Glycemic Velocity and Early Retinal Microvascular Change With GLP-1RA Versus SGLT2i Initiation in Type 2 Diabetes (GLIDE) | Trial register ClinicalTrials.gov |
| 2026-07-17 | Results | Results posted: A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants | Trial register ClinicalTrials.gov |
| 2026-07-16 | Trial | New trial registered: Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV | Trial register ClinicalTrials.gov |
| 2026-07-15 | Trial | New trial registered: Effect of Tirzepatide on Diabetic Peripheral Sensorimotor Neuropathy | Trial register ClinicalTrials.gov |
| 2026-07-14 | Trial | New trial registered: Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists | Trial register ClinicalTrials.gov |
| 2026-07-14 | Trial | New trial registered: Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity | Trial register ClinicalTrials.gov |
| 2026-07-13 | Trial | New trial registered: AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2026-07-13 | Trial | New trial registered: High-protein plUs reSistance Training in gLucagon-like pEptide 1 Receptor Agonist Users (HUSTLE) | Trial register ClinicalTrials.gov |
| 2026-07-12 | Trial | New trial registered: A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With | Trial register ClinicalTrials.gov |
| 2026-07-09 | Trial | New trial registered: An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder | Trial register ClinicalTrials.gov |
| 2026-07-08 | Recall | FDA recall, Class II: Lupin Pharmaceuticals Inc.. CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing | Regulator FDA enforcement reports |
| 2026-07-08 | Results | Results posted: A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2026-07-08 | Trial | New trial registered: Assessing Follow up Trajectories in Eating, Routines, and Weight After GLP-1 | Trial register ClinicalTrials.gov |
| 2026-07-07 | Label | FDA label revised: Gvoke VialDx (NDA212097) | Regulator FDA drug label register |
| 2026-07-06 | Trial | New trial registered: Effects of an Arabinoxylan-enriched Rusk on Postprandial Glucose, Insulin, Glucagon-like Peptide-1 and Appetite Responses | Trial register ClinicalTrials.gov |
| 2026-07-03 | Trial | New trial registered: A Clinical Study of FT1 in Patients With Short Bowel Syndrome | Trial register ClinicalTrials.gov |
| 2026-07-02 | Results | Results posted: Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists | Trial register ClinicalTrials.gov |
| 2026-06-30 | Trial | New trial registered: Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial | Trial register ClinicalTrials.gov |
| 2026-06-29 | Trial | New trial registered: Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes | Trial register ClinicalTrials.gov |
| 2026-06-26 | Trial | New trial registered: Tirzepatide in the Treatment of Cannabis Use Disorder | Trial register ClinicalTrials.gov |
| 2026-06-25 | Trial | New trial registered: The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy Individuals | Trial register ClinicalTrials.gov |
| 2026-06-24 | Trial | New trial registered: GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation | Trial register ClinicalTrials.gov |
| 2026-06-22 | Results | Results posted: Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3 | Trial register ClinicalTrials.gov |
| 2026-06-19 | Label | FDA label revised: Baqsimi (NDA210134) | Regulator FDA drug label register |
| 2026-06-17 | Trial | New trial registered: Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists. | Trial register ClinicalTrials.gov |
| 2026-06-11 | Trial | New trial registered: Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy | Trial register ClinicalTrials.gov |
| 2026-06-08 | Trial | New trial registered: GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity | Trial register ClinicalTrials.gov |
| 2026-06-05 | Trial | New trial registered: Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF | Trial register ClinicalTrials.gov |
| 2026-06-04 | Trial | New trial registered: Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE) | Trial register ClinicalTrials.gov |
| 2026-06-03 | Trial | New trial registered: Estimating the Impact of Obesity Medications on Clinical and Economic Outcomes | Trial register ClinicalTrials.gov |
| 2026-06-02 | Trial | New trial registered: Tirzepatide vs Semaglutide in Individuals at Cardiovascular Risk But Without Diabetes. | Trial register ClinicalTrials.gov |
| 2026-06-01 | Results | Results posted: Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese Subjects | Trial register ClinicalTrials.gov |
| 2026-05-31 | Trial | New trial registered: Antidiabetic Medications and Risk of Cancer | Trial register ClinicalTrials.gov |
| 2026-05-29 | Trial | New trial registered: A Trial of Oral VRB-103 Alone or in Combination With Oral Ecnoglutide (VRB-101) in Participants With Obesity or Overweight | Trial register ClinicalTrials.gov |
| 2026-05-29 | Trial | New trial registered: SHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes. | Trial register ClinicalTrials.gov |
| 2026-05-28 | Trial | New trial registered: GLP-1 RA Cessation and Gastric Ultrasound Findings | Trial register ClinicalTrials.gov |
| 2026-05-28 | Trial | New trial registered: Effects of Inulin on Cardiometabolic Risk Factors in Individuals Using Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA ) Medications for Weight | Trial register ClinicalTrials.gov |
| 2026-05-22 | Trial | New trial registered: Multi-Site Trial of Tirzepatide for Smoking Cessation | Trial register ClinicalTrials.gov |
| 2026-05-22 | Trial | New trial registered: Tirzepatide in the Treatment of Endometrial Cancer | Trial register ClinicalTrials.gov |
| 2026-05-20 | Trial | New trial registered: Fecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2026-05-19 | Trial | New trial registered: RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM) | Trial register ClinicalTrials.gov |
| 2026-05-15 | Trial | New trial registered: Myokines as Potential Biomarkers and Drivers of Sarcopenia in Metabolic and Endocrine Diseases | Trial register ClinicalTrials.gov |
| 2026-05-15 | Trial | New trial registered: GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study | Trial register ClinicalTrials.gov |
| 2026-05-15 | Trial | New trial registered: Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs | Trial register ClinicalTrials.gov |
| 2026-05-15 | Trial | New trial registered: Use of Liraglutide in Children Aged 6 to 12 Years With Severe Obesity | Trial register ClinicalTrials.gov |
| 2026-05-14 | Trial | New trial registered: Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay. | Trial register ClinicalTrials.gov |
| 2026-05-09 | Trial | New trial registered: The Effects of LEUVATE on Glycemia, Insulinemia, Aminoacidemia, and Protein Synthesis in GLP-1 RA-treated Adults | Trial register ClinicalTrials.gov |
| 2026-05-08 | Trial | New trial registered: Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Ob | Trial register ClinicalTrials.gov |
| 2026-05-08 | Trial | New trial registered: Tirzepatide Titration to Reduce Side Effects in Individuals With Obesity | Trial register ClinicalTrials.gov |
| 2026-05-07 | Trial | New trial registered: Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion | Trial register ClinicalTrials.gov |
| 2026-05-05 | Trial | New trial registered: CARTIZ Registry: Cartilage, Arthropathy and Imaging Under Tirzepatide in Zone-stratified Cohorts - A Four-Institute Mexican Observational Registry | Trial register ClinicalTrials.gov |
| 2026-05-01 | Federal Register | Federal Register notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act | Regulator Federal Register |
| 2026-04-30 | Trial | New trial registered: Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD) | Trial register ClinicalTrials.gov |
| 2026-04-30 | Trial | New trial registered: Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist | Trial register ClinicalTrials.gov |
| 2026-04-29 | Trial | New trial registered: AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN) | Trial register ClinicalTrials.gov |
| 2026-04-28 | Trial | New trial registered: Incretin Therapies in Obesity-related HFpEF | Trial register ClinicalTrials.gov |
| 2026-04-24 | Label | FDA label revised: Glucagon (ANDA204468) | Regulator FDA drug label register |
| 2026-04-23 | Trial | New trial registered: Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD) | Trial register ClinicalTrials.gov |
| 2026-04-17 | Trial | New trial registered: Glucagon-like Peptide 2 (GLP-2) in Undernourished Women Improving From Histology-Confirmed Environmental Enteric Dysfunction (EED) | Trial register ClinicalTrials.gov |
| 2026-04-14 | Trial | New trial registered: A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD | Trial register ClinicalTrials.gov |
| 2026-04-14 | Trial | New trial registered: Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes | Trial register ClinicalTrials.gov |
| 2026-04-13 | Trial | New trial registered: Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder | Trial register ClinicalTrials.gov |
| 2026-04-13 | Trial | New trial registered: Adiponectin in Patients With Metabolic Disorders | Trial register ClinicalTrials.gov |
| 2026-04-13 | Trial | New trial registered: Efficacy and Safety of HDM1005 Compared to Tirzepatide in Obese Adults Without Diabetes | Trial register ClinicalTrials.gov |
| 2026-04-06 | Trial | New trial registered: Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy | Trial register ClinicalTrials.gov |
| 2026-04-02 | Trial | New trial registered: A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comor | Trial register ClinicalTrials.gov |
| 2026-04-01 | Trial | New trial registered: Exploring the Influence of Glucagon-like Peptide -1 (GLP-1) Medications on Food Cravings, Food Selection, and Food Intake Following Exposure to Food | Trial register ClinicalTrials.gov |
| 2026-03-31 | Trial | New trial registered: Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity | Trial register ClinicalTrials.gov |
| 2026-03-27 | Trial | New trial registered: Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis | Trial register ClinicalTrials.gov |
| 2026-03-25 | Trial | New trial registered: Safety and Effectiveness of Tirzepatide in Patients With Obesity at Hospital de Clínicas, Paraguay | Trial register ClinicalTrials.gov |